Subscribe to Newsletter

Content by Stephanie Vine:

Manufacture Advanced Medicine

Kite, CAR Ts, and Access for Patients

| Stephanie Vine | 9 min read

We sat down with Kite’s Cindy Perettie to talk about access to CAR Ts.

Business & Regulation Profession

Medicine Making Pioneers

| Stephanie Vine

From Carl June to Peter Marks to Kiran Mazumdar-Shaw; check out our thought provoking interviews with some of the biggest names in the pharma field.

Discovery & Development Drug Discovery

The Golden Ticket For Obesity Drug Development

| Stephanie Vine | 6 min read

We speak to the 2025 winner of Novo Nordisk and Pioneer Group’s Golden Ticket program.

Manufacture Facilities

FUJIFILM Diosynth and Regeneron Sign 10-Year, $3 Billion Manufacturing Agreement

| Stephanie Vine | 2 min read

FUJIFILM Diosynth to manufacture biologics for Regeneron at new facility in Holly Springs, North Carolina.

Discovery & Development Dosage Forms

Going From Benchtop Chemist to CEO: Part 2

| Stephanie Vine | 5 min read

We speak with Colorcon CEO Simon Tasker about the importance of the patient experience when it comes to medicines.

Business & Regulation Profession

From Benchtop Chemist to CEO

| Stephanie Vine | 5 min read

Simon Tasker joined Colorcon as a bench chemist – and never left. Today, he’s the company’s CEO. Here’s how his career unfolded.

Manufacture Advanced Medicine

Cell Therapy: Getting GMP Right

| Stephanie Vine | 2 min read

Open-access research paper outlines quality and regulatory considerations for cell therapy manufacturing programs.

Business & Regulation Profession

The Blood Cancer Success Story: Part 2

| Stephanie Vine | 6 min read

Lore Gruenbaum discusses The Leukemia & Lymphoma Society, advances in blood cancers, and the role of nonprofits.

Discovery & Development Drug Discovery

Three Amazing Medicine Making Stories

| Stephanie Vine | 3 min read

Ivermectin, Viagra and warfarin; I look at the origins of three popular drugs and the role of serendipity.

Discovery & Development Drug Discovery

The Shingles Vaccine and Dementia

| Stephanie Vine | 2 min read

Studies have suggested that the RZV shingles vaccine can lower the risk of dementia; GSK is now investigating further.

Register to The Medicine Maker

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:
  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Medicine Maker magazine

Register